We're not selling seats yet. We're choosing a small group of practices and labs to build the product with, at founder pricing that stays locked as we grow.
The terms are built to lower your risk and raise your influence.
A full workup on five of your patients at no cost, so you see the output on real cases before anything else is decided.
The rate you start at is the rate you keep, even as list pricing rises after launch. Early belief is rewarded.
You talk to the people building it, and the roadmap bends toward what you actually need in the room.
We turn your real-world results into case studies that build your authority and ours, with your name on the science.
Design partner is a real relationship, not a free trial. Here's both sides of it.
A free proof-of-concept, founder-locked pricing for as long as you stay, direct access to the team, and a genuine say in what gets built next.
That you run CellWise on real patients, tell us candidly what works and what doesn't, and let us document the outcomes into shared case studies.
So you know what you're locking in. Design partners hold founder rates against all of it.
A per-practitioner monthly subscription for portal access and continuous, assay-independent surveillance, the layer that keeps earning between screens. Founder rate locked for partners.
A per-screen price for the single-cell analysis itself, offered in tiers. Partners lock today's founder rate before list pricing is set.